⌘K

Kronos Bio, Inc. (KRON)

$0.95 2.99% $0.03 Healthcare

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase inhibitor for acute myeloid leukemia patients. The company planned registrational phase 3 clinical trial of ENTO in combination with induction chemotherapy in acute myeloid leukemia patients with NPM1 mutations. It is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors, which is in phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in San Mateo, California.

Market cap

$57.14M

CEO

Dr. Norbert W. Bischofberger Ph.D.

Full time employees

101.00

Headquarters

San Mateo, CA

IPO Date

Oct 09, 2020

Price-to-earnings (PE) Ratio

-0.54

Earnings-per-share (EPS)

$-1.74

Cash ratio (TTM)

4.22

Current ratio (TTM)

8.49

Net profit margin (TTM)

-1,222.83%

PE ratio (TTM)

-0.55

PEG ratio (TTM)

0.00

Price-to-book ratio (TTM)

0.46

Price-to-sales ratio (TTM)

6.76

Quick ratio (TTM)

8.49

Return on assets (TTM)

-62.61%

Return on equity (TTM)

-68.82%

Similar stocks (17)

Crinetics Pharmaceuticals, Inc.

CRNX

$53.88 2.10% $1.11

Uptrend

Edgewise Therapeutics, Inc.

EWTX

$29.50 54.69% $10.43

Uptrend

Erasca, Inc.

ERAS

$2.97 2.77% $0.08

Uptrend

Replimune Group, Inc.

REPL

$11.23 1.35% $0.15

Uptrend

Larimar Therapeutics, Inc.

LRMR

$7.14 4.23% $0.29

Downtrend

C4 Therapeutics, Inc.

CCCC

$6.57 2.98% $0.19

Neutral

Lyell Immunopharma, Inc.

LYEL

$1.56 15.56% $0.21

Downtrend

Inhibrx, Inc.

INBX

$17.49 2.94% $0.50

Downtrend

Gossamer Bio, Inc.

GOSS

$0.96 5.35% $0.05

Downtrend

Generation Bio Co.

GBIO

$2.86 10.42% $0.27

Downtrend

Nuvectis Pharma, Inc.

NVCT

$6.75 0.75% $0.05

Downtrend

Assembly Biosciences, Inc.

ASMB

$18.50 1.82% $0.33

Uptrend

CytomX Therapeutics, Inc.

CTMX

$1.17 -1.68% $-0.02

Downtrend

Spero Therapeutics, Inc.

SPRO

$1.36 1.12% $0.02

Downtrend

NextCure, Inc.

NXTC

$1.43 2.14% $0.03

Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.28 2.67% $0.00

Downtrend

Cyclerion Therapeutics, Inc.

CYCN

$2.83 0.71% $0.02

Downtrend

ETF Exposure (9)

iShares Micro-Cap ETF

IWC

0.01245%

$126.54 2.19% $2.71

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.96 1.07% $0.53

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.95 1.07% $0.53

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.94 1.05% $0.52

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$137.33 1.73% $2.34

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$137.30 1.73% $2.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend

Downtrend

Similar stocks (17)

Crinetics Pharmaceuticals, Inc.

CRNX

$53.88 2.10% $1.11

Uptrend

Edgewise Therapeutics, Inc.

EWTX

$29.50 54.69% $10.43

Uptrend

Erasca, Inc.

ERAS

$2.97 2.77% $0.08

Uptrend

Replimune Group, Inc.

REPL

$11.23 1.35% $0.15

Uptrend

Larimar Therapeutics, Inc.

LRMR

$7.14 4.23% $0.29

Downtrend

C4 Therapeutics, Inc.

CCCC

$6.57 2.98% $0.19

Neutral

Lyell Immunopharma, Inc.

LYEL

$1.56 15.56% $0.21

Downtrend

Inhibrx, Inc.

INBX

$17.49 2.94% $0.50

Downtrend

Gossamer Bio, Inc.

GOSS

$0.96 5.35% $0.05

Downtrend

Generation Bio Co.

GBIO

$2.86 10.42% $0.27

Downtrend

Nuvectis Pharma, Inc.

NVCT

$6.75 0.75% $0.05

Downtrend

Assembly Biosciences, Inc.

ASMB

$18.50 1.82% $0.33

Uptrend

CytomX Therapeutics, Inc.

CTMX

$1.17 -1.68% $-0.02

Downtrend

Spero Therapeutics, Inc.

SPRO

$1.36 1.12% $0.02

Downtrend

NextCure, Inc.

NXTC

$1.43 2.14% $0.03

Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.28 2.67% $0.00

Downtrend

Cyclerion Therapeutics, Inc.

CYCN

$2.83 0.71% $0.02

Downtrend

ETF Exposure (9)

iShares Micro-Cap ETF

IWC

0.01245%

$126.54 2.19% $2.71

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.96 1.07% $0.53

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.95 1.07% $0.53

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.94 1.05% $0.52

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$137.33 1.73% $2.34

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$137.30 1.73% $2.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend